Loading organizations...
Loading organizations...
Biologic drug development using engineered human stem cell proteins.
Juvena Therapeutics has raised $74.5M across 2 funding rounds.
Juvena Therapeutics has raised $74.5M in total across 2 funding rounds.
Juvena Therapeutics has raised $74.5M in total across 2 funding rounds.
Juvena Therapeutics's investors include Ben Hemani, Eli Lilly and Company, Laura Lande-Diner, Manta Ray Ventures, Mubadala Capital, Patrick Zhang, Ayman AlAbdallah, Jeff Dean, Karl Pfleger, Alumni Ventures, Bison Ventures, BoxOne Ventures.
Juvena Therapeutics has raised $74.5M across 2 funding rounds. Most recently, it raised $33.5M Series B in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 12, 2026 | $33.5M Series B | Ben Hemani | Eli Lilly and Company, Laura Lande-Diner, Manta Ray Ventures, Mubadala Capital |
| Nov 8, 2022 | $41.0M Series A | Patrick Zhang, Ayman AlAbdallah | Jeff Dean, Karl Pfleger, Alumni Ventures, Bison Ventures, BoxOne Ventures, Felicis Ventures, Intersect VC, Irongrey, Manta Ray Ventures, Metamorphic Ventures, Plum Alley, Transform VC |